| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mai―28 |
DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS-CoV-2 Respiratory Infection Compromise Inflammation and Cellular Metabolism |
April Rees, Oliver Richards, Molly E Raikes, Megan Chambers, Sophie G Reed, Ceri Battle, Hannah Toghill, Luke Newey, Tyler J Joseph, Haiyan An, Hui Zhang, Iain Perry, Jason Webber, Nicholas Jones, Catherine A Thornton |
| 2 |
[GO] |
2026―Apr―30 |
When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration |
Gunjan Bawne, Loet Coenen, Erik Nutma, Jinte Middeldorp, Magdalena J. Lorenowicz |
| 3 |
[GO] |
2026―Mrz―13 |
Reduced Mortality in COVID-19 Patients Treated With Inhaled Extracellular Vesicles Expressing CD24 |
Shiran Shapira, Guy Vishnevsky, Hadas Yaakobi, Gil Shenberg, Mays Motlaq, Eliezer Liberman, Aminadav Kalisky, Gadi Benari, Sotirios Tsiodras, Nimrod Adi, Jan Lötvall, Nadir Arber |
| 4 |
[GO] |
2025―Apr―10 |
Extracellular Vesicles Alter Trophoblast Function in Pregnancies Complicated by COVID-19 |
Thea N. Golden, Sneha Mani, Rebecca L. Linn, Rita Leite, Natalie A. Trigg, Annette Wilson, Lauren Anton, Monica Mainigi, Colin C. Conine, Brett A. Kaufman, Jerome F. Strauss, Samuel Parry, Rebecca A. Simmons |
| 5 |
[GO] |
2024―Nov―19 |
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19 |
Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, Muthukumar Gunasekaran, Edward M. Pickering, Stephanie Avila, Etse Gebru, Eduardo Becerril-Vargas, Sergio Monraz-Perez, Kapil Saharia, Alison Grazioli, Michael T. McCurdy, Matthew Frieman, Lisa Miorin, Alessandro Russo, Andrés F. Cardona, Adolfo García-Sastre, Sunjay Kaushal, Fred R. Hirsch, Djordje Atanackovic, Susmita Sahoo, Oscar Arrieta, Christian Rolfo |
| 6 |
[GO] |
2024―Sep―10 |
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury |
Jun Ho Lee, Hyungtaek Jeon, Jan Lötvall, Byong Seung Cho |
| 7 |
[GO] |
2024―Jul―25 |
Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial |
Mohammad Hossein Zamanian, Amir Hossein Norooznezhad, Zohreh Hosseinkhani, Daryoush Hassaninia, Feizollah Mansouri, Siavash Vaziri, Mehrdad Payandeh, Fatemeh Heydarpour, Sara Kiani, Maria Shirvani, Mojgan Rajati, Mitra Bakhtiari, Farzaneh Esmaili, Reza Yarani, Kamran Mansouri |
| 8 |
[GO] |
2024―Jul―15 |
CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection |
Rosa Suades, Maria Francesca Greco, Paula Prieto, Teresa Padró, Yvan Devaux, Pere Domingo, Lina Badimon |
| 9 |
[GO] |
2024―Feb―10 |
Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological response |
Hannah K. Jackson, Heather M. Long, Juan Carlos Yam-Puc, Roberta Palmulli, Tracey A. Haigh, Pehuén Pereyra Gerber, Jin S. Lee, Nicholas J. Matheson, Lesley Young, John Trowsdale, Mathew Lo, Graham S. Taylor, James E. Thaventhiran, James R. Edgar |
| 10 |
[GO] |
2022―Dez―21 |
The importance of activated TMPRSS2 in the proviral role of small extracellular vesicles in SARS-CoV-2 infection |
Sze Keong Tey, Judy Wai Ping Yam |
| 11 |
[GO] |
2022―Dez―05 |
Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS-CoV-2 infected human lung epithelial cells |
Supasek Kongsomros, Nutkridta Pongsakul, Jirawan Panachan, Ladawan Khowawisetsut, Jinjuta Somkird, Chak Sangma, Tapanee Kanjanapruthipong, Patompon Wongtrakoongate, Arthit Chairoungdua, Kovit Pattanapanyasat, David S. Newburg, Ardythe L. Morrow, Suradej Hongeng, Arunee Thitithanyanont, Somchai Chutipongtanate |
| 12 |
[GO] |
2022―Dez―01 |
Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2 |
Xiaohang Chen, Huifei Li, Haoyue Song, Jie Wang, Xiaoxuan Zhang, Pengcheng Han, Xing Wang |
| 13 |
[GO] |
2022―Okt―22 |
Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection |
François Berry, Margot Morin-Dewaele, Amene Majidipur, Thibaud Jamet, Sophie Bartier, Eva Ignjatovic, Donatella Toniutti, Jeanne Gaspar Lopes, Pascale Soyeux-Porte, Pascale Maillé, Carolina Saldana, Rozenn Brillet, Nazim Ahnou, Laurent Softic, Benoit Couturaud, Éric Huet, Abdelhakim Ahmed-Belkacem, Slim Fourati, Bruno Louis, André Coste, Émilie Béquignon, Alexandre de la Taille, Damien Destouches, Francis Vacherot, Jean-Michel Pawlotsky, Virginie Firlej, Patrice Bruscella |
| 14 |
[GO] |
2022―Aug―18 |
Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients |
Tobias Tertel, Sergej Tomić, Jelena Đokić, Dušan Radojević, Dejan Stevanović, Nataša Ilić, Bernd Giebel, Maja Kosanović |
| 15 |
[GO] |
2022―Mai―18 |
ACE2-enriched extracellular vesicles enhance infectivity of live SARS-CoV-2 virus |
Sze Keong Tey, Hoiyan Lam, Samuel Wan Ki Wong, Hanjun Zhao, Kelvin Kai-Wang To, Judy Wai Ping Yam |
| 16 |
[GO] |
2022―Mai―09 |
Erratum: A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants |
|
| 17 |
[GO] |
2022―Mrz―15 |
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants |
Linglei Jiang, Tom A.P. Driedonks, Wouter S.P. Jong, Santosh Dhakal, H. Bart van den Berg van Saparoea, Ioannis Sitaras, Ruifeng Zhou, Christopher Caputo, Kirsten Littlefield, Maggie Lowman, Mengfei Chen, Gabriela Lima, Olesia Gololobova, Barbara Smith, Vasiliki Mahairaki, M. Riley Richardson, Kathleen R. Mulka, Andrew P. Lane, Sabra L. Klein, Andrew Pekosz, Cory Brayton, Joseph L. Mankowski, Joen Luirink, Jason S. Villano, Kenneth W. Witwer |
| 18 |
[GO] |
2022―Jan―04 |
Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection |
Hark Kyun Kim, Junhyung Cho, Eunae Kim, Junsik Kim, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Younmin Shin, Leon F. Palomera, Jinsu Park, Seung Hyun Baek, Han-Gyu Bae, Yoonsuk Cho, Jihoon Han, Jae Hoon Sul, Jeongmi Lee, Jae Hyung Park, Yong Woo Cho, Wonsik Lee, Dong-Gyu Jo |
| 19 |
[GO] |
2021―Dez―07 |
Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles |
Keesiang Lim, Goro Nishide, Takeshi Yoshida, Takahiro Watanabe-Nakayama, Akiko Kobayashi, Masaharu Hazawa, Rikinari Hanayama, Toshio Ando, Richard W. Wong |
| 20 |
[GO] |
2021―Dez―02 |
Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients |
Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, Linus Rinke, Johannes C. Hellmuth, Clemens Scherer, Maximilian Muenchhoff, Christopher Mandel, Michael Bergwelt-Baildon, Mikael Simons, Tobias Straub, Anne B. Krug, Jan Kranich, Thomas Brocker |
| 21 |
[GO] |
2021―Jul―04 |
Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity |
Balaji Krishnamachary, Christine Cook, Ashok Kumar, Leslie Spikes, Prabhakar Chalise, Navneet K. Dhillon |
| 22 |
[GO] |
2021―Jun―19 |
Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies |
Zach Troyer, Najwa Alhusaini, Caroline O. Tabler, Thomas Sweet, Karina Inacio Ladislau Carvalho, Daniela M. Schlatzer, Lenore Carias, Christopher L. King, Kenneth Matreyek, John C. Tilton |
| 23 |
[GO] |
2021―Jun―04 |
Early prediction of COVID-19 severity using extracellular vesicle COPB2 |
Yu Fujita, Tokio Hoshina, Juntaro Matsuzaki, Yusuke Yoshioka, Tsukasa Kadota, Yusuke Hosaka, Shota Fujimoto, Hironori Kawamoto, Naoaki Watanabe, Kenji Sawaki, Yohei Sakamoto, Makiko Miyajima, Kwangyole Lee, Kazuhiko Nakaharai, Tetsuya Horino, Ryo Nakagawa, Jun Araya, Mitsuru Miyato, Masaki Yoshida, Kazuyoshi Kuwano, Takahiro Ochiya |
| 24 |
[GO] |
2020―Dez―29 |
Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus |
Federico Cocozza, Nathalie Névo, Ester Piovesana, Xavier Lahaye, Julian Buchrieser, Olivier Schwartz, Nicolas Manel, Mercedes Tkach, Clotilde Théry, Lorena Martin-Jaular |
| 25 |
[GO] |
2020―Dez―03 |
COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? |
Philip W. Askenase |
| 26 |
[GO] |
2020―Aug―24 |
Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection |
Carina Conzelmann, Rüdiger Groß, Min Zou, Franziska Krüger, André Görgens, Manuela O Gustafsson, Samir El Andaloussi, Jan Münch, Janis A. Müller |
| 27 |
[GO] |
2020―Aug―06 |
Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19? |
Kasra Khalaj, Rebeca Lopes Figueira, Lina Antounians, Giuseppe Lauriti, Augusto Zani |
|
